Page 201 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis
P. 201

In: The Vasculitides, Volume 1               ISBN: 978-1-63463-110-5
Editors: David S. Younger       © 2015 Nova Science Publishers, Inc.

                                                                    Chapter 10

      Classification and Pathogenicity
        of ANCA-Associated Vasculitis

          Constantina Yiannakis, M.D., Lorna Ward, M.D. and
        Matthew David Morgan, M.B., Ch.B., M.R.C.P., Ph.D.?

    Renal Immunobiology, Centre for Translational Inflammation Research, School of
              Immunity and Infection, College of Medical and Dental Sciences,
                           University of Birmingham, Birmingham, UK

                                   Abstract

          Anti-neutrophil cytoplasm antibody-associated vasculitides include several distinct
     multisystemic disorders, the diagnosis of which relies upon recognition of a compatible
     clinical syndrome supported by radiological, immunological and histological laboratory
     findings. If unrecognized, there may be significant delays in treatment culminating in
     multiorgan morbidity. Their pathogenesis is complex involving both innate and adaptive
     immune systems with loss of tolerance to autoantigens leading to the production of
     antibodies that activate cytokine-primed neutrophils. The factors leading to production of
     pathogenic autoantibodies is incompletely understood but may involve cross-reactivity to
     bacterial antigens and the expression of complementary peptides. T-cells appear to have a
     role in both loss of self-tolerance and in the cause of tissue injury. Moreover, peripheral
     blood T-cells show evidence of persistent activation driven partly by cytomegalovirus
     infection. Activation of the alternative complement pathway has recently emerged as a
     significant pathogenic mechanism in the development of glomerulonephritis.

Keywords: ANCA, Vasculitis, Pathogenesis, Classification, ANCA-Associated Vasculitis

? Corresponding author: Matthew David Morgan, M.B., Ch.B., M.R.C.P., Ph.D. Centre for Translational
      Inflammation Research, University of Birmingham Research Laboratories, Queen Elizabeth Hospital
      Birmingham, Mindelsohn Way, Edgbaston, Birmingham, B15 2WB. E-mail: m.d.morgan @bham.ac.uk.

            Complimentary Contributor Copy
   196   197   198   199   200   201   202   203   204   205   206